0000899243-18-005338.txt : 20180223 0000899243-18-005338.hdr.sgml : 20180223 20180223171438 ACCESSION NUMBER: 0000899243-18-005338 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180222 FILED AS OF DATE: 20180223 DATE AS OF CHANGE: 20180223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPICKSCHEN THORLEF CENTRAL INDEX KEY: 0001268374 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 18637620 MAIL ADDRESS: STREET 1: TRAUBENWEG 25 CITY: 64342 SEEHEIN-JUGENHEIM STATE: 2M ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-22 0 0001466301 Clovis Oncology, Inc. CLVS 0001268374 SPICKSCHEN THORLEF C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 1 0 0 0 Common Stock 2018-02-22 4 S 0 4500 60.00 D 16618 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2017. Exhibit List /s/ Thorlef Spickschen 2018-02-23